Last week, a federal judge ruled that the Food and Drug Administration (FDA) cannot prohibit a pharmaceutical company from marketing its drugs for off-label uses if its claims are truthful and not misleading. This ruling,...more
A divided panel of the Second U.S. Circuit Court of Appeals has thrown out the conviction of a pharmaceutical sales representative who marketed a narcolepsy drug for so-called off-label uses not approved by the Food and Drug...more